Design Strategies for Hyaluronic Acid-based Drug Delivery Systems in Cancer Immunotherapy

被引：1

作者：

Rodella, Giulia ^{[1
,2
]}

Preat, Veronique ^{[1
]}

Gallez, Bernard ^{[2
]}

Malfanti, Alessio ^{[1
,3
]}

机构：

[1] UCLouvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, Ave Mounier 73 B1-73-12, B-1200 Brussels, Belgium

[2] UCLouvain, Louvain Drug Res Inst, Biomed Magnet Resonance, Ave Mounier 73 B1-73-08, B-1200 Brussels, Belgium

[3] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Via F Marzolo 5, I-35131 Padua, Italy

来源：

JOURNAL OF CONTROLLED RELEASE | 2025年 / 383卷

基金：

欧洲研究理事会;

关键词：

Hyaluronic acid; Drug delivery systems; Cancer immunotherapy; Immunomodulation; Vaccines; CD44; TUMOR-ASSOCIATED MACROPHAGES; MOLECULAR-WEIGHT; BREAST-CANCER; CD44-HYALURONAN INTERACTIONS; DENDRITIC CELLS; CD44; CLEAVAGE; EXPRESSION; NANOPARTICLES; RECEPTOR; CONJUGATE;

D O I：

10.1016/j.jconrel.2025.113784

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Despite its robust therapeutic potential, cancer immunotherapy has provided little progress towards improved survival rates for patients bearing immunologically refractory tumors. The implementation of advanced drug delivery systems represents a powerful means of improving cancer immunotherapy by relieving immunosuppression and promoting immune response; however, the overall impact of these systems on immunotherapy currently remains modest. Hyaluronic acid represents a widely used polymer in drug delivery; meanwhile, recent studies linking hyaluronic acid to the immune system make this polymer an attractive component in the design of next-generation cancer immunotherapies. Herein, we review our current understanding of the immunological properties of hyaluronic acid and discuss them in the context of bioactive functions and immune-related interactions with receptors, immune, and cancer cells. We analyze the potential of hyaluronic acid as a component in advanced drug delivery systems, highlighting strategies for the design of more effective vaccines and cancer chemo-immunotherapies. Finally, we discuss critical considerations to facilitate design and clinical translation to overcome existing challenges and maximize therapeutic potential.

引用

页数：22

共 213 条

[11] Hyaluronic acid: More than a carrier, having an overpowering extracellular and intracellular impact on cancer [J].

Bhattacharyya, Medha ;

Jariyal, Heena ;

Srivastava, Akshay .

CARBOHYDRATE POLYMERS, 2023, 317

[12] Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells [J].

Bourguignon, L. Y. W. ;

Earle, C. ;

Wong, G. ;

Spevak, C. C. ;

Krueger, K. .

ONCOGENE, 2012, 31 (02) :149-160

[13] Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression [J].

Bourguignon, Lilly Y. W. .

SEMINARS IN CANCER BIOLOGY, 2008, 18 (04) :251-259

[14] Hyaluronic Acid: A Review of the Drug Delivery Capabilities of This Naturally Occurring Polysaccharide [J].

Buckley, Ciara ;

Murphy, Emma J. ;

Montgomery, Therese R. ;

Major, Ian .

POLYMERS, 2022, 14 (17)

[15] NF-kB and caspases are involved in the hyaluronan and chondroitin-4-sulphate-exerted antioxidant effect in fibroblast cultures exposed to oxidative stress [J].

Campo, Giuseppe M. ;

Avenoso, Angela ;

Campo, Salvatore ;

D'Ascola, Angela ;

Traina, Paola ;

Sama, Dario ;

Calatroni, Alberto .

JOURNAL OF APPLIED TOXICOLOGY, 2008, 28 (04) :509-517

[16] Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes [J].

Campo, Giuseppe M. ;

Avenoso, Angela ;

Campo, Salvatore ;

D'Ascola, Angela ;

Nastasi, Giancarlo ;

Calatroni, Alberto .

BIOCHIMIE, 2010, 92 (02) :204-215

[17] Revisiting the hallmarks of cancer: The role of hyaluronan [J].

Caon, Ilaria ;

Bartolini, Barbara ;

Parnigoni, Arianna ;

Carava, Elena ;

Moretto, Paola ;

Viola, Manuela ;

Karousou, Evgenia ;

Vigetti, Davide ;

Passi, Alberto .

SEMINARS IN CANCER BIOLOGY, 2020, 62 :9-19

[18] Hyaluronan as an immunological adjuvant: a novel application for an ancient molecule [J].

Carpanese, D. ;

Pieta, A. Dalla ;

Rosato, A. .

CELLULAR & MOLECULAR IMMUNOLOGY, 2023, 20 (10) :1251-1253

[19] Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival [J].

Catania, Giuseppina ;

Rodella, Giulia ;

Vanvarenberg, Kevin ;

Preat, Veronique ;

Malfanti, Alessio .

BIOMATERIALS, 2023, 294

[20] Key roles of hyaluronan and its CD44 receptor in the sternness and survival of cancer stern cells [J].

Chanmee, Theerawut ;

Ontong, Pawared ;

Kimata, Koji ;

Nano, Naoki .

FRONTIERS IN ONCOLOGY, 2015, 5

← 1 2 3 4 5 6 7 8 9 10 →